Florida

Back to map

Showing 1-10 of 24 grants

Title Institution Researcher Program Duration Total Award Amount
Repurposing Cardiorenal Drugs for T1D: Building Evidence from Existing Trials (ReCaRD T1D) AdventHealth Richard Pratley Improving Lives 01-September-2023 to 31-August-2025 $110,840.00
Advanced Preclinical Development of iTOL-101, a Combination Investigational Product Composed of A Biotechnology-Derived Chimeric Streptavidin and A Fas Ligand (SA-FasL) Protein Bound to Biotinylated Hydrogel-Based Microparticles (Microgel) and Mixed with Deceased Donor Human Pancreatic Islets for the Treatment of Poorly-Controlled (or “Brittle”) Type 1 Diabetes iTolerance, Inc. Camillo Ricordi Cures 01-June-2022 to 31-August-2025 $850,000.00
JDRF T1D Coordinating Center Jaeb Center for Health Research Judy Sibayan Transportfolio 01-August-2019 to 31-August-2027 $2,914,531.01
A Phase 2 Study Evaluating Short-Term Efficacy of Tonabersat (Xiflam) for Diabetic Macular Edema Jaeb Center for Health Research Adam Glassman Improving Lives 01-September-2022 to 01-January-2026 $273,424.00
Randomized Clinical Trial Evaluating Fenofibrate for Prevention of Diabetic Retinopathy Worsening Jaeb Center for Health Research Adam Glassman Improving Lives 01-February-2021 to 31-January-2026 $750,000.00
Transdisciplinary Care for Young Adults with Type 1 Diabetes Transitioning to Adult Healthcare Nemours Children's Clinic Jessica Pierce Improving Lives 01-May-2023 to 30-April-2026 $628,819.87
Restoration of immune regulation in type 1 diabetes through the synergistic action of insulin-like growth factor-1 and interleukin-2 University of Florida Todd Brusko Cures 01-September-2024 to 31-August-2026 $500,000.00
Deep Learning-based Analyses of Pancreatic Islet Beta-Cell Heterogeneity and MRI Pancreas Volume as Biomarkers to Improve Understanding of Type 1 Diabetes Progression University of Florida Sarah Kim Cures 01-June-2022 to 31-May-2026 $750,000.00
Network for Pancreatic Organ Donors – nPOD University of Florida Mark Atkinson Cures 01-October-2023 to 30-September-2026 $8,100,000.00
Orthogonal engineering to suppress autoreactive T cell activation in T1D cell therapy University of Florida Jessie Barra Cures 01-March-2024 to 28-February-2027 $285,000.00